论文部分内容阅读
目的观察病毒唑联合盐酸氨溴索压缩雾化吸入治疗毛细支气管炎的疗效。方法选择婴幼儿毛细支气管炎82例,随机分为观察组与对照组。两组病人均采用综合治疗。观察组40例予以病毒唑联合盐酸氨溴索雾化吸入治疗,每日3次,连用7天。对比观察呼吸困难改善情况、肺部湿啰音消失情况及住院天数?峁?观察组的呼吸困难减轻程度、肺部啰音吸收情况及平均住院日均较对照组有明显改善,P<0.05,统计学具有显著差异。结论病毒唑联合盐酸氨溴索雾化吸入治疗毛细支气管炎,能较快的改善患儿的呼吸情况、肺部啰音及缩短住院天数,且无明显副作用,值得临床推广。
Objective To observe the efficacy of ribavirin combined with ambroxol hydrochloride in the treatment of bronchiolitis. Methods 82 cases of infant bronchiolitis were selected and randomly divided into observation group and control group. Two groups of patients were treated with comprehensive treatment. Observation group of 40 patients were treated with ribavirin ribavirin ribavirin inhalation therapy, 3 times daily, once every 7 days. Compared with the observation of improvement of dyspnea condition, the disappearance of pulmonary wet rales and the number of days of hospitalization, the degree of dyspnea, pulmonary rales absorption and average length of stay in the observation group were significantly improved compared with the control group (P <0.05) , Statistically significant difference. Conclusions Ribavirin combined with inhalation of ambroxol hydrochloride inhalation for the treatment of bronchiolitis can rapidly improve the respiratory status, pulmonary rales and shorten the length of stay in hospital without obvious side effects, which is worthy of clinical promotion.